We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+11.13%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.52B
AUM Growth
+$329M
Cap. Flow
+$28.7M
Cap. Flow %
0.64%
Top 10 Hldgs %
9.29%
Holding
626
New
45
Increased
211
Reduced
278
Closed
71

Top Buys

Rank Stock Value
1
HLIO icon
Helios Technologies
HLIO
+$35.4M
2
QCRH icon
QCR Holdings
QCRH
+$27.2M
3
ENS icon
EnerSys
ENS
+$23.7M
4
CNOB icon
Center Bancorp
CNOB
+$18.9M
5
SXI icon
Standex International
SXI
+$15.8M

Sector Composition

Rank Sector Weight
1 Industrials 19.99%
2 Financials 19.92%
3 Healthcare 18.11%
4 Technology 12.75%
5 Consumer Discretionary 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOP icon
526
Koppers
KOP
$894M
$613K 0.01%
21,898
-86,537
-80% -$2.66M
IRON icon
527
Disc Medicine
IRON
$3.12B
$597K 0.01%
+9,028
New +$537K
MGTX icon
528
MeiraGTx Holdings
MGTX
$1.21B
$570K 0.01%
69,243
+34,054
+97% +$269K
KYMR icon
529
Kymera Therapeutics
KYMR
$8.99B
$537K 0.01%
9,482
+4,646
+96% +$210K
NTRA icon
530
Natera
NTRA
$45.9B
$518K 0.01%
3,220
+1,552
+93% +$246K
TRVI icon
531
Trevi Therapeutics
TRVI
$2.51B
$503K 0.01%
54,933
+27,082
+97% +$203K
BDTX icon
532
Black Diamond Therapeutics
BDTX
$116M
$492K 0.01%
129,944
+64,069
+97% +$187K
QRHC icon
533
Quest Resource Holding
QRHC
$31.2M
$491K 0.01%
314,947
+3,658
+1% +$6.78K
NTLA icon
534
Intellia Therapeutics
NTLA
$1.68B
$458K 0.01%
26,514
+13,005
+96% +$160K
ARCT icon
535
Arcturus Therapeutics
ARCT
$213M
$421K 0.01%
22,825
+11,151
+96% +$179K
POR icon
536
Portland General Electric
POR
$5.69B
$332K 0.01%
7,555
MX icon
537
Magnachip Semiconductor
MX
$141M
$330K 0.01%
105,551
+40,959
+63% +$139K
JPM icon
538
JPMorgan Chase
JPM
$962B
$296K 0.01%
938
-26,392
-97% -$7.85M
KTCC icon
539
Key Tronic
KTCC
$44.2M
$287K 0.01%
80,265
-118,843
-60% -$365K
GOOGL icon
540
Alphabet (Google) Class A
GOOGL
$4.27T
$281K 0.01%
1,156
-91,624
-99% -$19.2M
JANX icon
541
Janux Therapeutics
JANX
$1.02B
$279K 0.01%
11,413
+1,905
+20% +$46.4K
RZLT icon
542
Rezolute
RZLT
$454M
$274K 0.01%
+29,180
New +$194K
EME icon
543
Emcor
EME
$35.8B
$274K 0.01%
422
CGEM icon
544
Cullinan Oncology
CGEM
$1.24B
$273K 0.01%
46,011
+33,837
+278% +$248K
AMD icon
545
Advanced Micro Devices
AMD
$761B
$265K 0.01%
1,640
VLO icon
546
Valero Energy
VLO
$93B
$254K 0.01%
1,493
FHN icon
547
First Horizon
FHN
$12B
$253K 0.01%
11,194
GS icon
548
Goldman Sachs
GS
$302B
$251K 0.01%
315
-11,280
-97% -$8.36M
XEL icon
549
Xcel Energy
XEL
$48.3B
$248K 0.01%
3,074
CIVI
550
DELISTED
Civitas Resources
CIVI
$231K 0.01%
7,102
-81,254
-92% -$2.6M

Similar funds

Kennedy Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Kennedy Capital Management held 626 positions worth $4.52B, up 7.9% from $4.19B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Kennedy Capital Management's Q3 2025 filing shows 45 new, 211 increased, 278 reduced and 71 closed positions. Its largest new stake was Helios Technologies: 757,786 shares worth $39.5M. The largest sale was NVIDIA, an estimated $35.1M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Kennedy Capital Management's largest Q3 2025 buy was Helios Technologies: 757,786 shares worth $39.5M.
  • Kennedy Capital Management added most to QCR Holdings in Q3 2025, an estimated $27.2M increase.
  • Kennedy Capital Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $35.1M.
  • Kennedy Capital Management fully exited Pinnacle Financial Partners Inc in Q3 2025, selling an estimated $24.6M.
  • Kennedy Capital Management's ten largest holdings make up 9.3% of its $4.52B portfolio in Q3 2025.
  • Kennedy Capital Management opened 45 new positions and closed 71 in Q3 2025.
  • Kennedy Capital Management's portfolio value rose 7.9% quarter-over-quarter to $4.52B.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.